M&A Deal Summary

Roche Acquires Innovatis AG

On March 16, 2009, Roche acquired life science company Innovatis AG from VM Capital for 15M EUR

Acquisition Highlights
  • This is Roche’s 8th transaction in the Life Science sector.
  • This is Roche’s 27th largest (disclosed) transaction.
  • This is Roche’s 1st transaction in Germany.

M&A Deal Summary

Date 2009-03-16
Target Innovatis AG
Sector Life Science
Buyer(s) Roche
Sellers(s) VM Capital
Deal Type Add-on Acquisition
Deal Value 15M EUR

Target

Innovatis AG

Bielefeld, Germany
website
Innovatis AG develops, produces and distributes fully automated cell analysis equipment (bioprocess analysis). The systems overcome the drawbacks of manual analysis such as the high amounts of time and work involved, the restricted data that is acquired and the high margin of error.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Roche

Basel, Switzerland

website


Category Company
Founded 1896
Sector Life Science
Employees100,920
Revenue 63.3B CHF (2022)
DESCRIPTION
Roche's corporate headquarters in Basel, Switzerland.
Roche's corporate headquarters in Basel, Switzerland.

Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.


DEAL STATS #
Overall 11 of 42
Sector (Life Science) 8 of 29
Type (Add-on Acquisition) 9 of 35
Country (Germany) 1 of 4
Year (2009) 2 of 2
Size (of disclosed) 27 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-03-12 Genentech

San Francisco, California, United States

Genentech is a biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The Company is based in San Francisco.

Buy $46.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-15 PVT Probenverteiltechnik

Waiblingen, Germany

PVT Probenverteiltechnik GmbH providing customised automation and workflow solutions for in-vitro diagnostic (IVD) testing in large commercial and hospital laboratories.

Buy -

Seller(S) 1

SELLER

VM Capital

Dusseldorf, Germany

Investor

website


Category Private Equity Firm
Founded 2000
PE ASSETS 675M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

VM Capital (formerly known as Ventizz Capital Partners) is a private equity firm that targets investments in growth-oriented technology businesses operating throughout Europe. VM Capital will consider investing in individual companies as well as acquisitions of secondary private equity transactions. Specific sectors of interest include renewable energy/clean technology, semiconductors, electronics, photonics, materials applicaton, industrial automation, medical technology, IT, and communications. Vorndran looks for control stakes when making investments. The Firm's investment horizon is 3 to 6 years. VM Capital was formed in 2000 and is based in Dusseldorf.


DEAL STATS #
Overall 8 of 19
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 6
Country (Germany) 6 of 13
Year (2009) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-01-22 Visioncard

Kematen, Austria

Visioncard Kunststoffkarten-Produktions GmbH, based in Kematen/Austria, specializes in producing and printing chipcards and plastic cards. Visioncard is geared to larger volumes and has market-leading competence in all of the standard printing methods (offset, screen, thermal sublimation and thermal transfer printing).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-01 Medi-Globe

Stuttgart, Germany

Medi-Globe is a developer, producer, and distributor of medical instruments, catheters, implants, and wound care, focusing on minimal-invasive and non-invasive endoscopy applications. Medi-Globe was founded in 1985 and is based in Stuttgart, Germany.

Sell -